632
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Optimizing insulin pump therapy: the potential advantages of using a structured diabetes management program

, , , , , , , , , , , & show all
Pages 477-485 | Accepted 06 Jan 2015, Published online: 11 Feb 2015

References

  • Klupa T, Benbenek-Klupa T, Malecki M, et al. Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion. J Int Med Res 2008;36:1112-16
  • Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705
  • Hendrychova T, Matoulkova P, Vlcek J, Smahelova A. [An overview of so far published analyses comparing the effectiveness of treatment with insulin pump and multiple daily injections in type 1 diabetes mellitus]. Vnitr Lek 2012;58:89-93
  • Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 2008;25:765-74
  • Jeitler K, Horvath K, Berghold A, et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-51
  • Churchill JN, Ruppe RL, Smaldone A. Use of continuous insulin infusion pumps in young children with type 1 diabetes: a systematic review. J Pediatr Health Care 2009;23:173-9
  • Pankowska E, Bazik M, Dziechciarz P, et al. Continuous subcutaneous insulin infusion vs multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10:52-8
  • Jeha GS, Karaviti LP, Anderson B, et al. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 2005;7:876-84
  • Skogsberg L, Fors H, Hanas R, et al. Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr Diabetes 2008;9:472-9
  • Hofer SE, Heidtmann B, Raile K, et al. Initiative DPVS, the German working group for insulin pump treatment in pediatric patients: discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria. Pediatr Diabetes 2010;11:116-21
  • Barnard K, Parkin C, Young A, Ashraf M. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections. J Diab Sci Tech 2012;6:144-9
  • Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34
  • Azar M, Gabbay R. Web-based management of diabetes through glucose uploads: has the time come for telemedicine? Diabetes Res Clin Pract 2009;83:9-17
  • Weissmann JMA, Pralle K, Ruessmann H-J, et al. Information management improves medical outcome and supports therapy decision in diabetes care: results from the multicenter observational VISION study. Diabetologie und Stoffwechsel 2012;7:112
  • Skeie S, Kristensen GBB, Carlsen S, Sandberg S. Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol 2009;3:83-8
  • Kato NC, Cui J, Kato M. Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes. J Diabetes Investig 2013;4:450
  • Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011;34:262-7
  • Duran A, Martin P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2010;2:203-11
  • Franciosi M, Lucisano G, Pellegrini F, et al. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med 2011;28:789--96
  • Kempf K, Kruse J, Martin S. ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther 2010;12:547-53
  • Lalic N, Tankova T, Nourredine M, et al. Value and utility of structured self-monitoring of blood glucose in real world clinical practice: findings from a multinational observational study. Diabetes Technol Ther 2012;14:338-43
  • Lange K. Therapieadhärenz bei Typ 1 Diabetes. Herausforderung, Barrieren und Chancen. Der Diabetologe 2012;1:1-10
  • Ceriello A, Barkai L, Christiansen JS, et al. Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract 2012;98:5-10
  • Schwarzer R. Modeling health behavior change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol Int Rev 2008;57:1-29
  • Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995;18:754-60
  • Powell PW, Hilliard ME, Anderson BJ. Motivational interviewing to promote adherence behaviors in pediatric type 1 diabetes. Curr Diab Rep 2014;14:531
  • Gayes LA, Steele RG. A meta-analysis of motivational interviewing interventions for pediatric health behavior change. J Consult Clin Psychol 2014;82:521-35
  • Landers B, Weissmann J, Steinbrinker LC, et al. NOTOS: an electronic questionnaire structures individualised diabetes management. P-1130. Poster presentation at European Association for the Study of Diabetes (EASD), Barcelona, Spain, 23–27 September 2013
  • Reimer A, Ehrmann D, Kulzer B, et al. Development and evaluation of a psychometric assessment of the ability of valid bolus calculation and estimation carbohydrate (SMART). Diabetologie und Stoffwechsel 2012: doi: 10.1055/s-0032-1314468
  • National Institute for Health and Care Excellence (NICE). Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE technology appraisals [TA151]. 2008. Available at: http://www.nice.org.uk/guidance/TA151/chapter/1-guidance [Last accessed 10 September 2014]
  • Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med 2005;22:1379-85
  • Müller UA, Hunger-Dathe W, Müller N, et al. Langzeitglykämie und Hypoglykämien nach Teilnahme am strukturierten Behandlungs- und Schulungsprogramm, Insulinpumpen-Therapie für erwachsene Patienten mit Diabetes mellitus Typ 1. von Roche Diagnostics GmbH. Diabet Stoffw 2007;2:161-8
  • Cavan D, Ziegler R, Cranston I, et al. Use of an insulin bolus advisor facilitates earlier, more frequent changes in insulin therapy parameters in sub-optimally controlled patients with diabetes treated with multiple daily insulin injection (MDI) therapy: results of the ABACUs trial. Diabetes Technol Ther 2014;16:310-16
  • Ziegler R, Tubili C, Chico A, et al. ProAct Studie: Neue Funktionen von Insulinpumpen verbessern Diabetes-Management und glykämische Kontrolle bei Patienten mit Typ 1 Diabetes mellitus nach Umstellung von CSII Systemen unter täglichen Routinebedingungen. Diabetologie und Stoffwechsel 2013;8:185
  • Standards of Medical Care in Diabetes – 2014. Diabetes Care. American Diabetes Association. 2014;37(Suppl 1):S14-80
  • Hirsch IB. Blood glucose monitoring technology: translating data into practice. Endocr Pract 2004;10:67-76
  • Given JE, O’Kane MJ, Bunting BP, Coates VE. Comparing patient-generated blood glucose diary records with meter memory in diabetes: a systematic review. Diabet Med 2013;30:901-13
  • Kazlauskaite R, Soni S, Evans AT, et al. Accuracy of self-monitored blood glucose in type 2 diabetes. Diabetes Technol Ther 2009;11:385-92
  • Berg J, Dodd S, Dodd S. The role of a community pharmacist in diabetes education: practice matters. SA Pharmaceutical J 2010;55:55-7
  • Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabet Med 2004;21:150-5
  • Grant RW, Buse JB, Meigs JB. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005;28:337-442
  • Corriveau EA, Durso PJ, Kaufman ED, et al. Effect of Carelink, an internet-based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Pediatr Diabetes 2008;9:360-6
  • Reichel A, Rietzsch H, Ludwig B, et al. Self-adjustment of insulin dose using graphically depicted self-monitoring of blood glucose measurements in patients with type 1 diabetes mellitus. J Diabetes Sci Technol 2013;7:156-62
  • Bandura A. Self-efficacy: the exercise of control. New York: Freeman, 1997
  • Loveman E, Frampton GK, Clegg AJ. The clinical effectiveness of diabetes education models for type 2 diabetes: a systematic review. Health Technol Assess 2008;12:1-136
  • Hinnen DA, Buskirk A, Lyden M, et al. Use of diabetes data management software reports by health care providers, patients with diabetes, and caregivers improves accuracy and efficiency of data analysis and interpretation compared with traditional logbook data: first results of the Accu-Chek Connect Reports Utility and Efficiency Study (ACCRUES). J Diab Sci Techn 2012;7:FV 36. published online 2 November 2014, doi:10.1177/1932296814557188

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.